Behshad Sheldon

Board Member, President Camurus Inc.

Behshad Sheldon (born 1963) is Board Member since 2018. She is also Member of the Remuneration Committee. Also, she is since 1 April, 2024, President of Camurus Inc. 

Her work experience includes the position as President & CEO of Braeburn Pharmaceuticals until 2017. She has also extensive global and US experience from various senior positions in international pharmaceutical companies, including Smithkline Beecham, Bristol-Myers Squibb, Otsuka Pharmaceuticals and as EVP & Managing Director, Biotech Value Advisors.

Beshad holds a B.Sc. in Neuroscience from University of Rochester.

Other current appointments: Chairman of the Board of FORCE (Female Opioid Research and Clinical Experts) in Princeton, New Jersey, Board member of Maxona Pharmaceuticals, Philadelphia, Pennsylvania and of Egetis Therapeutics, Stockholm, Sweden.

Holdings: 1,000 shares

Independent in relation to the company’s major shareholders, but not the company and its management.